The first edition of the Botton-Champalimaud International Pancreatic Conference, hosted at the prestigious Botton-Champalimaud Pancreatic Cancer Centre, was a landmark event in 2024, bringing together leading experts, researchers, and healthcare professionals from around the world to discuss the latest advancements in pancreatic cancer diagnosis, treatment, and care.

The future of medicine is being redefined by artificial intelligence. From digital twins and precision medicine to AI-driven medical imaging and large language models, cutting-edge technologies are transforming the way we diagnose, treat, and prevent disease.

Additionally, we will explore the ongoing evolution of minimally invasive techniques and their impact on the patient's quality of life, even on complex cases, such as lateral compartment resections in rectal cancer and D3 lymphadenectomy in colon cancer.

This 2-day conference organised by the Champalimaud Foundation, in partnership with Faculdade de Motricidade Humana, will provide an overview of the scientific landscape in the area of physical activity and cancer, from prevention to rehabilitation and survivorship.

These are exciting times for research in this space as physical activity becomes more widely recognised as a powerful partner in the prevention and treatment of cancer.

This conference stands as a landmark event for the Botton-Champalimaud Pancreatic Cancer Centre in 2024 and will unite leading minds in translational science, oncology and surgery to tackle the complexities of pancreatic cancer.

The conference will serve as a pivotal platform for the exchange of groundbreaking insights, state-of-the-art surgical methodologies, and innovative therapeutic approaches that will ultimately enhance patient care and outcomes on a global scale.

Getting Doctors and Technologists to Talk About Artificial Intelligence

On the occasion of the Artificial Intelligence Appreciation Day, a conference will be held at the Champalimaud Foundation aimed at bridging the gap between AI innovation and its implementation in medical practice.

The goal of the MEDICA AI - The Conference, which will take place on July 16 at the Champalimaud Foundation (FC), is to familiarise healthcare professionals, with the latest AI tools so that they can apply them in their daily practice for the benefit of patients.

Join us for the FAITH Project's closing conference, where we'll delve into the crucial intersection of the FAITH AI technology and trials as well as key issues of mental health, survivorship in cancer and lessons learnt.

Meeting Description

This meeting collaboration between the Association for Cancer Immunotherapy CIMT and the Champalimaud Foundation will address promising paths towards effective cellular treatment modalities for patients with solid cancer and discuss the boundaries of synthetically engineered immune cells. The meeting will also discuss the innovation gap between academic and small biotech driven research, and the challenges of safe, biologically, and clinically relevant phase I / II clinical trials. 

This year's 7th Champalimaud Cancer Nurse Conference is poised to explore the theme inspired by Bob Dylan's iconic song "The Times They Are A-Changin'".

In an constantly evolving world, the ability to adjust to emerging realities is a necessity. Within the healthcare sector, this principle significantly influences the restructuring of services and patient care.

Cancer patients comprise about 15-20% of all patients admitted into Intensive Care Units (Bos et al. 2015; Shimalbukuro-Vornhagen et al. 2016); Approximately 50% of these admissions are due to surgical procedures, while the other 50% is related to medical causes, with only 3.3% corresponding to specific causes of oncological disease (Puxty et al. 2015).